Extracellular Vesicles Contain Putative Cancer Biomarkers

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Extracellular vesicles (EVs) are increasingly recognized for their role in cancer progression.
• EVs are heterogeneous and reflect the state of their parent cancer cells.
• Their presence in biological fluids makes them promising diagnostic and prognostic tools.

Purpose of the Study:

• To discuss the utility of cancer cell-derived EVs as a source of tumor-specific biomarkers.
• To explore the potential of EVs in early cancer diagnosis.
• To highlight the application of EVs in personalized medicine for predicting therapy response.

Main Methods:

• Review of emerging evidence and seminal studies on extracellular vesicles in cancer.
• Analysis of EV content heterogeneity and its relation to parent cell state.
• Evaluation of EV presence in biological fluids for diagnostic potential.

Main Results:

• EVs contain cargo reflecting their parent cell, making them rich sources of cancer biomarkers.
• Increased EV numbers in disease states support their diagnostic utility.
• EVs can serve as predictive biomarkers for patient response to therapy.

Conclusions:

• Cancer cell-derived EVs are valuable resources for early disease diagnosis.
• EVs can aid in personalized medicine, enabling tailored treatment strategies.
• Exploiting EVs as biomarkers can improve patient survival and quality of life.